New blood test aims to catch multiple cancers early in symptomatic patients
NCT ID NCT07390643
First seen Feb 05, 2026 · Last updated Jun 23, 2026 · Updated 16 times
Summary
This study will test a blood test called GRAIL Galleri that looks for signs of many different cancers at once. Researchers will give the test to 100 adults who have symptoms that might be cancer and are already being checked by doctors. They want to see how well the test finds cancer compared to standard methods, and what types and stages of cancer it detects or misses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
GRAIL Galleri MCED blood test
What this could lead to
If successful, this could show that a simple blood test helps detect various cancers earlier in people who already have symptoms, potentially improving treatment options.
What could go wrong
This is a small, early-stage study (100 participants) that has not yet started. The test may miss some cancers or give false positives, leading to unnecessary follow-up tests.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.